Welcome to the e-CCO Library!

P613: Mycophenolate mofetil is a valid option in patients with inflammatory bowel disease resistant to TNF-alpha inhibitors and conventional immunosuppressants
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Macaluso F.S.*1, Maida M.2, Renna S.1, Orlando E.1, Affronti M.1, Sapienza C.1, Dimarco M.1, Orlando R.1, Rizzuto G.1, Cottone M.1, Orlando A.1

Created: Wednesday, 20 February 2019, 10:36 AM
P613: Predictors of treatment persistence in ulcerative colitis patients treated with golimumab: A multicentre cohort study
Year: 2018
Source: ECCO '18 Vienna
Authors:

G. Biscaglia1, E. Savarino2, A. Variola3, F. Furfaro4, C. Ferracane5, G. Rizzati6, F. Scaldaferri6, G. Mocci7, A. Buda8, A. Privitera5, A. Geccherle3, G. Fiorino9,10*

Created: Thursday, 21 February 2019, 9:14 AM
P613: Social Media Analytics for Inflammatory Bowel Disease – What Are We Missing?
Year: 2021
Source: ECCO'21 Virtual
Authors: Kumar, L.(1);Kiely, L.(1);O'Riordan, A.(1);Barry, P.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P613: Switch from intravenous to subcutaneous maintenance infliximab in real world IBD cohort
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Mcgrory, L.(1)*;Goess, C.(1);Lynch, K.(1,2);
Created: Friday, 14 July 2023, 11:05 AM
P613: Tacrolimus as rescue therapy for steroid-dependent/steroid refractory ulcerative colitis: experience from tertiary referral centre
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Sud*1, A. S. Puri1

Created: Friday, 22 February 2019, 9:41 AM
P614 Micro-fragmented autologous adipose tissue injection for fistula-in-ano (MAATIFA) in patients with Crohn’s disease: A prospective observational study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Sturiale1, B. Fabiani1, D. Cafaro1, C. Menconi1, F. Celedon Porzio1, M. Franceschi2, G. Naldini1

Created: Thursday, 30 January 2020, 10:12 AM
P614: A strategy to solve complexity of physician diagnosis using a mixture of Patient Reports and Provider Reports: A Case Study of Crohn’s Disease Phenotypes
Year: 2021
Source: ECCO'21 Virtual
Authors: Zhang, L.(1);Fan, Y.(2);Thompson, J.(3);Bohn, R.(4);Negar, O.(4);Brodovicz, K.(2);Parakkal, D.(5);
Created: Wednesday, 2 June 2021, 4:12 PM
P614: Anti-TNFs more frequently stopped due to loss of response in British Asians with Crohn's disease: a single centre retrospective analysis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Gadhok R.1, Gordon H.*1, Sebepos-Rogers G.1, Baillie S.1, Akbar S.1, Ahmad O.F.1, Cooper B.1,2, Lindsay J.O.1,3

Created: Wednesday, 20 February 2019, 10:36 AM
P614: Pregnancy outcomes in women with IBD treated with biosimilar infliximab
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Kolar1*, D. Duricova1,2, M. Bortlik1,3, M. Lukas1, V. Hruba1, N. Machkova1, K. Malickova1, M. Lukas1,4

Created: Thursday, 21 February 2019, 9:14 AM
P614: Proactive infliximab is superior to either conventional infliximab and vedolizumab in Inflammatory Bowel Disease
Year: 2022
Source: ECCO'22
Authors: Rodrigues, I.(1);Serrazina, J.(1);Botto, I.(1);Fernandes, S.(1);Bernardo, S.(1);Gonçalves, A.R.(1);Moura Santos, P.(1);Valente, A.(1);Correia, L.(1);Tato Marinho, R.(1);
Created: Friday, 11 February 2022, 3:56 PM
P614: Reduction of bowel wall thickness and doppler signals as early as 36 hours predicts corticosteroid response in a multi-centre prospective cohort of Acute Severe Ulcerative Colitis: USUC Study including the GENIUS cohort
Year: 2023
Source: ECCO’23 Copenhagen
Authors: An, Y.K.(1)*;Fernandes, R.(1);Lindsay, N.(2);Khoo, E.(1);Pham, H.(2);Wong, K.F.(2);Thin, L.(3);Goodsall, T.(4);Bryant, R.V.(4);Wright, E.(5);Smith, R.(6);Friedman, A.(6);Begun, J.(1);
Created: Friday, 14 July 2023, 11:05 AM
P614: The utility as a biomarker of faecal calprotectin for predicting the clinical outcome of granulocyte and monocyte adsorptive apheresis treatment in patients with ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

N. Ueno*1, Y. Murakami1, T. Iwama1, T. Sasaki1, T. Kunogi1, K. Takahashi1, K. Tanaka2, K. Ando1, S. Kashima1, Y. Inaba3, K. Moriichi1, H. Tanabe1, M. Taruishi3, M. Fujiya1, T. Okumura1

Created: Friday, 22 February 2019, 9:41 AM
P615 Safety of vedolizumab in the treatment of IBD in a single tertiary centre
Year: 2020
Source:

ECCO'20 Vienna

Authors:

G. Peruzzi, L. Calandrini, H. Privitera Hrustemovic, M. Salice, A. Decorato, A. Carbone, F. Rizzello, A. Belluzzi, E. Scaioli, C. Calabrese, P. Gionchetti

Created: Thursday, 30 January 2020, 10:12 AM
P615: Does smoking really influence the development and the outcomes of Inflammatory Bowel Disease in Asian population? Results from the Taiwanese patients
Year: 2021
Source: ECCO'21 Virtual
Authors: Chen, B.C.(1);Weng, M.T.(2);Chang, C.H.(3);Huang, L.Y.(4);Wei, S.C.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P615: Efficacy of vedolizumab in patients with Crohn's disease may differ depending on the disease location: The UCLH experience
Year: 2018
Source: ECCO '18 Vienna
Authors:

T. Kumagai*, M. Vinayaga-Pavan, I. Parisi, J. Barragry, R. Sundramoorthi, L. Whitley, H. Parker, R. Kettle, N. McCabrey, E. Seward, S. McCartney, S. Bloom, R. Vega, S. Mehta, F. Rahman

Created: Thursday, 21 February 2019, 9:14 AM
P615: Improving IBD monitoring by understanding preanalytical faecal calprotectin variability
Year: 2022
Source: ECCO'22
Authors: Schröder, O.(1,2);Farrag, K.(1,2);Böcher, A.(3);Helmschrodt, A.(3);Aksan, A.(2,4);Ehehalt, R.(5);Stein, J.M.(1,2,6);
Created: Friday, 11 February 2022, 3:56 PM
P615: Rescue infliximab for acute severe colitis: a single-centre experience
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Orpen-Palmer*1, F. Clegg1,2, U. Basavaraju1, G. H. Bain1, C. N. Parnaby1, M. G. Smith1, M. H. McLean1,2, J. M. Thomson1

Created: Friday, 22 February 2019, 9:41 AM
P615: The unfinished symphony: golimumab is efficient in patients with refractory Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Greener T., Greenberg G., Steinhart H., Silverberg M.

Created: Wednesday, 20 February 2019, 10:36 AM
P616 IBD reference and biosimilar adalimumab CroSS over study (iBaSS): design considerations and methodology
Year: 2020
Source:

ECCO'20 Vienna

Authors:

D. Young1, U. Freudensprung2, C. Harris1, R. Harris1, J. Harvey3, J. Addison4, S. Latter5, F. Cummings1

Created: Thursday, 30 January 2020, 10:12 AM